Beijing Luzhu Biotechnology Balance Sheet Health
Financial Health criteria checks 5/6
Beijing Luzhu Biotechnology has a total shareholder equity of CN¥1.0B and total debt of CN¥7.0M, which brings its debt-to-equity ratio to 0.7%. Its total assets and total liabilities are CN¥1.2B and CN¥146.1M respectively.
Key information
0.7%
Debt to equity ratio
CN¥7.00m
Debt
Interest coverage ratio | n/a |
Cash | CN¥608.33m |
Equity | CN¥1.02b |
Total liabilities | CN¥146.07m |
Total assets | CN¥1.17b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2480's short term assets (CN¥621.0M) exceed its short term liabilities (CN¥96.3M).
Long Term Liabilities: 2480's short term assets (CN¥621.0M) exceed its long term liabilities (CN¥49.8M).
Debt to Equity History and Analysis
Debt Level: 2480 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2480's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2480 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 2480 has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 41% each year.